Center Laboratories, Inc.
TWO: 4123.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Su-Chi Wang
- Employees
- 182
- Headquarters
- Taipei, Taiwan
- IPO year
- 2007
- Market cap
- NT$28.6B
- Website
- https://www.centerlab.com.tw
Loading 4123…
Loading profile data…Frequently asked questions about 4123
What does Center Laboratories, Inc. (4123.TWO) do?
Center Laboratories, Inc. engages in the manufacture and trading of various medicines in Taiwan. It engages in the research and development of small molecule drugs; manufacture and sale of pharmaceuticals; development of proteins and antibodies; and pharmaceutical CDMO, medical device, nutritional health and agribiotechnology, stem cell and immu...
Where does 4123.TWO trade?
Center Laboratories, Inc. (4123.TWO) trades on the Taipei Exchange.
What sector is 4123.TWO in?
Center Laboratories, Inc. (4123.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Center Laboratories, Inc.?
Su-Chi Wang is the chief executive officer of Center Laboratories, Inc. (4123.TWO).
Where is Center Laboratories, Inc. headquartered?
Center Laboratories, Inc. is headquartered in Taiwan.
Does 4123.TWO pay a dividend?
Yes — Center Laboratories, Inc. (4123.TWO) paid a trailing twelve-month dividend of TWD 0.76 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4123.TWO go public?
Center Laboratories, Inc. (4123.TWO) completed its initial public offering in 2007.